awacke1/LOINC-Clinical-Terminology · Datasets at Hugging Face

LOINC_NUM stringlengths 3 8	COMPONENT stringlengths 2 246	PROPERTY stringlengths 1 29	TIME_ASPCT stringlengths 1 15	SYSTEM stringlengths 1 106	SCALE_TYP stringclasses 10 values	METHOD_TYP stringlengths 1 57 ⌀	CLASS stringlengths 2 24	CLASSTYPE int64 1 4	LONG_COMMON_NAME stringlengths 3 254	SHORTNAME stringlengths 2 51 ⌀	EXTERNAL_COPYRIGHT_NOTICE stringlengths 39 2.6k ⌀	STATUS stringclasses 4 values	VersionFirstReleased stringlengths 1 7	VersionLastChanged stringlengths 1 5
100002-5	Specimen care is maintained	Find	Pt	^Patient	Ord	null	SURVEY.PNDS	4	Specimen care is maintained	null	null	ACTIVE	2.72	2.72
100003-3	Team communication is maintained throughout care	Find	Pt	^Patient	Ord	null	SURVEY.PNDS	4	Team communication is maintained throughout care	null	null	ACTIVE	2.72	2.72
100004-1	Demonstrates knowledge of the expected psychosocial responses to the procedure	Find	Pt	^Patient	Ord	null	SURVEY.PNDS	4	Demonstrates knowledge of the expected psychosocial responses to the procedure	null	null	ACTIVE	2.72	2.72
100005-8	Demonstrates knowledge of nutritional management related to the procedure	Find	Pt	^Patient	Ord	null	SURVEY.PNDS	4	Demonstrates knowledge of nutritional management related to the procedure	null	null	ACTIVE	2.72	2.72
100006-6	Demonstrates knowledge of medication management	Find	Pt	^Patient	Ord	null	SURVEY.PNDS	4	Demonstrates knowledge of medication management	null	null	ACTIVE	2.72	2.72
100007-4	Demonstrates knowledge of pain management	Find	Pt	^Patient	Ord	null	SURVEY.PNDS	4	Demonstrates knowledge of pain management	null	null	ACTIVE	2.72	2.72
10000-8	R wave duration.lead AVR	Time	Pt	Heart	Qn	EKG	EKG.MEAS	2	R wave duration in lead AVR	R wave dur L-AVR	null	ACTIVE	1.0i	2.48
100008-2	Demonstrates knowledge of wound management	Find	Pt	^Patient	Ord	null	SURVEY.PNDS	4	Demonstrates knowledge of wound management	null	null	ACTIVE	2.72	2.72
100009-0	Demonstrates knowledge of the procedure and expected results	Find	Pt	^Patient	Ord	null	SURVEY.PNDS	4	Demonstrates knowledge of the procedure and expected results	null	null	ACTIVE	2.72	2.72
100010-8	No injury related to procedure equipment, medical supplies, or instrumentation	Find	Pt	^Patient	Ord	null	SURVEY.PNDS	4	No injury related to procedure equipment, medical supplies, or instrumentation	null	null	ACTIVE	2.72	2.72
100011-6	No injury related to an electrical source	Find	Pt	^Patient	Ord	null	SURVEY.PNDS	4	No injury related to an electrical source	null	null	ACTIVE	2.72	2.72
100012-4	Participates in decisions affecting the patient's plan of care	Find	Pt	^Patient	Ord	null	SURVEY.PNDS	4	Participates in decisions affecting the patient's plan of care	null	null	ACTIVE	2.72	2.72
100013-2	Participates in the discharge process	Find	Pt	^Patient	Ord	null	SURVEY.PNDS	4	Participates in the discharge process	null	null	ACTIVE	2.72	2.72
100014-0	Psychosocial health is maintained at or improved from baseline	Find	Pt	^Patient	Ord	null	SURVEY.PNDS	4	Psychosocial health is maintained at or improved from baseline	null	null	ACTIVE	2.72	2.72
100015-7	No injury related to positioning due to care or procedure	Find	Pt	^Patient	Ord	null	SURVEY.PNDS	4	No injury related to positioning due to care or procedure	null	null	ACTIVE	2.72	2.72
10001-6	R wave duration.lead I	Time	Pt	Heart	Qn	EKG	EKG.MEAS	2	R wave duration in lead I	R wave dur L-I	null	ACTIVE	1.0i	2.48
100016-5	No injury related to a laser source	Find	Pt	^Patient	Ord	null	SURVEY.PNDS	4	No injury related to a laser source	null	null	ACTIVE	2.72	2.72
100017-3	Perioperative nursing data set outcomes panel	-	Pt	^Patient	-	PNDS	PANEL.SURVEY.PNDS	4	Perioperative nursing data set outcomes panel [PNDS]	null	©AORN Syntegrity, Inc. Used with permission.Commercial or facility use requires a license from AORN Syntegrity or an authorized reseller.	ACTIVE	2.72	2.72
100018-1	Note	Find	Pt	{Setting}	Doc	Hospice care	DOC.ONTOLOGY	2	Hospice care Note	Hospice care Note	null	ACTIVE	2.72	2.72
100019-9	ALK gene targeted mutation analysis	Prid	Pt	Bld/Tiss	Nom	Molgen	MOLPATH.MUT	1	ALK gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal	ALK gene Mut Anl Bld/T	null	ACTIVE	2.72	2.72
100020-7	GNA11 gene targeted mutation analysis	Prid	Pt	Bld/Tiss	Nom	Molgen	MOLPATH.MUT	1	GNA11 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal	GNA11 gene Mut Anl Bld/T	null	ACTIVE	2.72	2.72
100021-5	GNAQ gene targeted mutation analysis	Prid	Pt	Bld/Tiss	Nom	Molgen	MOLPATH.MUT	1	GNAQ gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal	GNAQ gene Mut Anl Bld/T	null	ACTIVE	2.72	2.72
100022-3	IDH1 gene targeted mutation analysis	Prid	Pt	Bld/Tiss	Nom	Molgen	MOLPATH.MUT	1	IDH1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal	IDH1 gene Mut Anl Bld/T	null	ACTIVE	2.72	2.72
100023-1	IDH2 gene targeted mutation analysis	Prid	Pt	Bld/Tiss	Nom	Molgen	MOLPATH.MUT	1	IDH2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal	IDH2 gene Mut Anl Bld/T	null	ACTIVE	2.72	2.72
10002-4	R wave duration.lead II	Time	Pt	Heart	Qn	EKG	EKG.MEAS	2	R wave duration in lead II	R wave dur L-II	null	ACTIVE	1.0i	2.48
100024-9	SETBP1 gene targeted mutation analysis	Prid	Pt	Bld/Tiss	Nom	Molgen	MOLPATH.MUT	1	SETBP1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal	SETBP1 gene Mut Anl Bld/T	null	ACTIVE	2.72	2.72
100025-6	SRSF2 gene targeted mutation analysis	Prid	Pt	Bld/Tiss	Nom	Molgen	MOLPATH.MUT	1	SRSF2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal	SRSF2 gene Mut Anl Bld/T	null	ACTIVE	2.72	2.72
100026-4	MET gene targeted mutation analysis	Prid	Pt	Bld/Tiss	Nom	Molgen	MOLPATH.MUT	1	MET gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal	MET gene Mut Anl Bld/T	null	ACTIVE	2.72	2.72
100027-2	SMAD4 gene targeted mutation analysis	Prid	Pt	Bld/Tiss	Nom	Molgen	MOLPATH.MUT	1	SMAD4 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal	SMAD4 gene Mut Anl Bld/T	null	ACTIVE	2.72	2.72
100028-0	FBXW7 gene targeted mutation analysis	Prid	Pt	Bld/Tiss	Nom	Molgen	MOLPATH.MUT	1	FBXW7 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal	FBXW7 gene Mut Anl Bld/T	null	ACTIVE	2.72	2.72
100029-8	Cancer related multigene analysis	Find	Pt	Plas.cfDNA	Doc	Molgen	MOLPATH	1	Cancer related multigene analysis in Plasma cell-free DNA by Molecular genetics method	Cancer multigene analysis Plas.cfDNA	null	ACTIVE	2.72	2.72
100030-6	Axis I: Temporal aspects score	Score	Pt	^Patient	Qn	Mainz Pain Staging System	SURVEY.PAIN	4	Axis I: Temporal aspects score [Mainz Pain Staging System]	null	© 1999 H.U. Gerbershagen, J. Korb, B. Nagel, P. Nilges. Used with permission.	ACTIVE	2.72	2.72
100031-4	Axis II: Spatial aspects score	Score	Pt	^Patient	Qn	Mainz Pain Staging System	SURVEY.PAIN	4	Axis II: Spatial aspects score [Mainz Pain Staging System]	null	© 1999 H.U. Gerbershagen, J. Korb, B. Nagel, P. Nilges. Used with permission.	ACTIVE	2.72	2.72
10003-2	R wave duration.lead III	Time	Pt	Heart	Qn	EKG	EKG.MEAS	2	R wave duration in lead III	R wave dur L-III	null	ACTIVE	1.0i	2.48
100032-2	Axis III: Drug taking behavior score	Score	Pt	^Patient	Qn	Mainz Pain Staging System	SURVEY.PAIN	4	Axis III: Drug taking behavior score [Mainz Pain Staging System]	null	© 1999 H.U. Gerbershagen, J. Korb, B. Nagel, P. Nilges. Used with permission.	ACTIVE	2.72	2.72
100033-0	Axis IV: Utilization of the health care system score	Score	Pt	^Patient	Qn	Mainz Pain Staging System	SURVEY.PAIN	4	Axis IV: Utilization of the health care system score [Mainz Pain Staging System]	null	© 1999 H.U. Gerbershagen, J. Korb, B. Nagel, P. Nilges. Used with permission.	ACTIVE	2.72	2.72
100034-8	Provider of automated external defibrillator use	Type	Pt	^Patient	Nom	null	TRAUMA	2	Provider of automated external defibrillator use	Provider of AED	null	ACTIVE	2.72	2.72
100035-5	Exam finding location	Find	Pt	Chest	Nom	null	H&P.PX	2	Exam finding location of Chest	Exam finding location Chest	null	ACTIVE	2.72	2.72
100036-3	Exam finding location	Find	Pt	Lung	Nom	null	H&P.PX	2	Exam finding location of Lung	Exam finding location Lung	null	ACTIVE	2.72	2.72
100037-1	Patient contact disposition	Type	Pt	EMS unit	Nom	null	TRAUMA	2	Patient contact disposition EMS unit	Patient contact disposition EMS unit	null	ACTIVE	2.72	2.72
100038-9	Patient evaluation disposition	Type	Pt	EMS unit	Nom	null	TRAUMA	2	Patient evaluation disposition EMS unit	Patient eval disposition EMS unit	null	ACTIVE	2.72	2.72
100039-7	Crew disposition for patient care	Type	Pt	EMS unit	Nom	null	TRAUMA	2	Crew disposition for patient care EMS unit	Crew disposition EMS unit	null	ACTIVE	2.72	2.72
10004-0	R wave duration.lead V1	Time	Pt	Heart	Qn	EKG	EKG.MEAS	2	R wave duration in lead V1	R wave dur L-V1	null	ACTIVE	1.0i	2.48
100040-5	Patient transport disposition	Type	Pt	EMS unit	Nom	null	TRAUMA	2	Patient transport disposition EMS unit	Pt transport disposition EMS unit	null	ACTIVE	2.72	2.72
100041-3	Aminoglycoside	Susc	Pt	Isolate	OrdQn	null	ABXBACT	1	Aminoglycoside [Susceptibility]	Aminoglycoside Susc Islt	null	ACTIVE	2.72	2.72
100042-1	Atovaquone	Susc	Pt	Isolate	OrdQn	null	ABXBACT	1	Atovaquone [Susceptibility]	Atovaquone Susc Islt	null	ACTIVE	2.72	2.72
100043-9	Azithromycin+Ethambutol	Susc	Pt	Isolate	OrdQn	null	ABXBACT	1	Azithromycin+Ethambutol [Susceptibility]	Azithro+Ethambut Susc Islt	null	ACTIVE	2.72	2.72
100044-7	Cefcapene	Susc	Pt	Isolate	OrdQn	null	ABXBACT	1	Cefcapene [Susceptibility]	Cefcapene Susc Islt	null	ACTIVE	2.72	2.72
100045-4	Cefozopran	Susc	Pt	Isolate	OrdQn	null	ABXBACT	1	Cefozopran [Susceptibility]	Cefozopran Susc Islt	null	ACTIVE	2.72	2.72
100046-2	Cefquinome	Susc	Pt	Isolate	OrdQn	null	ABXBACT	1	Cefquinome [Susceptibility]	CEQ Susc Islt	null	ACTIVE	2.72	2.72
100047-0	Cefteram	Susc	Pt	Isolate	OrdQn	null	ABXBACT	1	Cefteram [Susceptibility]	Cefteram Susc Islt	null	ACTIVE	2.72	2.72
100048-8	Clarithromycin+Ethambutol	Susc	Pt	Isolate	OrdQn	null	ABXBACT	1	Clarithromycin+Ethambutol [Susceptibility]	Clarithro+Ethamb Susc Islt	null	ACTIVE	2.72	2.72
100049-6	Eravacycline	Susc	Pt	Isolate	OrdQn	null	ABXBACT	1	Eravacycline [Susceptibility]	Eravacycline Susc Islt	null	ACTIVE	2.72	2.72
100050-4	Erythromycin+Ethambutol	Susc	Pt	Isolate	OrdQn	null	ABXBACT	1	Erythromycin+Ethambutol [Susceptibility]	Erythro+Ethamb Susc Islt	null	ACTIVE	2.72	2.72
100051-2	Ethambutol+rifAMPin	Susc	Pt	Isolate	OrdQn	null	ABXBACT	1	Ethambutol+rifAMPin [Susceptibility]	Ethambutol+rifAMPin Susc Islt	null	ACTIVE	2.72	2.72
100052-0	Flomoxef	Susc	Pt	Isolate	OrdQn	null	ABXBACT	1	Flomoxef [Susceptibility]	Flomoxef Susc Islt	null	ACTIVE	2.72	2.72
100053-8	Fluoroquinolone	Susc	Pt	Isolate	OrdQn	null	ABXBACT	1	Fluoroquinolone [Susceptibility]	FLQ Susc Islt	null	ACTIVE	2.72	2.72
100054-6	Gamithromycin	Susc	Pt	Isolate	OrdQn	null	ABXBACT	1	Gamithromycin [Susceptibility]	Gamithromycin Susc Islt	null	ACTIVE	2.72	2.72
100055-3	Optochin	Susc	Pt	Isolate	OrdQn	null	ABXBACT	1	Optochin [Susceptibility]	Optochin Susc Islt	null	ACTIVE	2.72	2.72
100056-1	Panipenem	Susc	Pt	Isolate	OrdQn	null	ABXBACT	1	Panipenem [Susceptibility]	Panipenem Susc Islt	null	ACTIVE	2.72	2.72
10005-7	R wave duration.lead V2	Time	Pt	Heart	Qn	EKG	EKG.MEAS	2	R wave duration in lead V2	R wave dur L-V2	null	ACTIVE	1.0i	2.48
100057-9	Prothionamide	Susc	Pt	Isolate	OrdQn	null	ABXBACT	1	Prothionamide [Susceptibility]	Prothionamide Susc Islt	null	ACTIVE	2.72	2.72
100058-7	Prulifloxacin	Susc	Pt	Isolate	OrdQn	null	ABXBACT	1	Prulifloxacin [Susceptibility]	Prulifloxacin Susc Islt	null	ACTIVE	2.72	2.72
100059-5	Rifapentine	Susc	Pt	Isolate	OrdQn	null	ABXBACT	1	Rifapentine [Susceptibility]	Rifapentine Susc Islt	null	ACTIVE	2.72	2.72
100060-3	Tildipirosin	Susc	Pt	Isolate	OrdQn	null	ABXBACT	1	Tildipirosin [Susceptibility]	Tildipirosin Susc Islt	null	ACTIVE	2.72	2.72
100061-1	Tosufloxacin	Susc	Pt	Isolate	OrdQn	null	ABXBACT	1	Tosufloxacin [Susceptibility]	Tosufloxacin Susc Islt	null	ACTIVE	2.72	2.72
100062-9	Standard Dermatology Outcome Measures panel	-	Pt	^Patient	-	SDOM	PANEL.CLIN	2	Standard Dermatology Outcome Measures panel	SDOM panel	Copyright © 2016 The Regents of the University of California and Emory University. Used with permission.	ACTIVE	2.72	2.72
100063-7	Primary skin concern	Find	Pt	^Patient	Nom	null	CLIN	2	Primary skin concern	Primary skin concern	null	ACTIVE	2.72	2.72
100064-5	Itch severity	Find	RptPeriod	^Patient	Ord	Reported	CLIN	2	Itch severity Reporting Period - Reported	Itch severity RptPeriod Reported	null	ACTIVE	2.72	2.72
10006-5	R wave duration.lead V3	Time	Pt	Heart	Qn	EKG	EKG.MEAS	2	R wave duration in lead V3	R wave dur L-V3	null	ACTIVE	1.0i	2.48
100065-2	Satisfied with treatment	Find	Pt	^Patient	Ord	null	CLIN	2	Satisfied with treatment	Satisfied with treatment	null	ACTIVE	2.72	2.72
100066-0	Specular microscopy panel	-	Pt	Eye	-	Specular microscopy	PANEL.EYE	2	Specular microscopy panel	Specular microscopy panel	null	TRIAL	2.72	2.72
100067-8	Image magnification	Len	Pt	Eye	Qn	null	EYE.SPECULAR MICROSCOPY	2	Eye Image magnification	Eye Image magnification	null	TRIAL	2.72	2.72
100068-6	Fixation point	Angle	Pt	Eye.right	Nom	null	EYE.SPECULAR MICROSCOPY	2	Right eye Fixation point [Angle]	R eye Fixation point [Angle]	null	TRIAL	2.72	2.72
100069-4	Fixation point	Angle	Pt	Eye.left	Nom	null	EYE.SPECULAR MICROSCOPY	2	Left eye Fixation point [Angle]	L eye Fixation point [Angle]	null	TRIAL	2.72	2.72
100070-2	Cell density	Naric	Pt	Cornea.right	Qn	null	EYE.SPECULAR MICROSCOPY	2	Right cornea Cell density	R cornea Cell density	null	TRIAL	2.72	2.72
100071-0	Cell density	Naric	Pt	Cornea.left	Qn	null	EYE.SPECULAR MICROSCOPY	2	Left cornea Cell density	L cornea Cell density	null	TRIAL	2.72	2.72
100072-8	Coefficient of variation	ArLen	Pt	Cornea.right	Qn	null	EYE.SPECULAR MICROSCOPY	2	Right cornea Coefficient of variation	R cornea Coefficient of variation	null	TRIAL	2.72	2.72
10007-3	R wave duration.lead V4	Time	Pt	Heart	Qn	EKG	EKG.MEAS	2	R wave duration in lead V4	R wave dur L-V4	null	ACTIVE	1.0i	2.48
100073-6	Coefficient of variation	ArLen	Pt	Cornea.left	Qn	null	EYE.SPECULAR MICROSCOPY	2	Left cornea Coefficient of variation	L cornea Coefficient of variation	null	TRIAL	2.72	2.72
100074-4	Hexagonality	RelRto	Pt	Cornea.right	Qn	null	EYE.SPECULAR MICROSCOPY	2	Right cornea Hexagonality	R cornea Hexagonality	null	TRIAL	2.72	2.72
100075-1	Hexagonality	RelRto	Pt	Cornea.left	Qn	null	EYE.SPECULAR MICROSCOPY	2	Left cornea Hexagonality	L cornea Hexagonality	null	TRIAL	2.72	2.72
100076-9	Endothelial cells counted	Num	Pt	Cornea.right	Qn	null	EYE.SPECULAR MICROSCOPY	2	Right cornea Endothelial cells counted	R cornea Endothelial cells counted	null	TRIAL	2.72	2.72
100077-7	Endothelial cells counted	Num	Pt	Cornea.left	Qn	null	EYE.SPECULAR MICROSCOPY	2	Left cornea Endothelial cells counted	L cornea Endothelial cells counted	null	TRIAL	2.72	2.72
100078-5	Endothelial cell area.min	Area	Pt	Cornea.right	Qn	null	EYE.SPECULAR MICROSCOPY	2	Right cornea Endothelial cell area.min	R cornea Endothelial cell area.min	null	TRIAL	2.72	2.72
100079-3	Endothelial cell area.min	Area	Pt	Cornea.left	Qn	null	EYE.SPECULAR MICROSCOPY	2	Left cornea Endothelial cell area.min	L cornea Endothelial cell area.min	null	TRIAL	2.72	2.72
100080-1	Endothelial cell area.max	Area	Pt	Cornea.right	Qn	null	EYE.SPECULAR MICROSCOPY	2	Right cornea Endothelial cell area.max	R cornea Endothelial cell area.max	null	TRIAL	2.72	2.72
10008-1	R wave duration.lead V5	Time	Pt	Heart	Qn	EKG	EKG.MEAS	2	R wave duration in lead V5	R wave dur L-V5	null	ACTIVE	1.0i	2.48
100081-9	Endothelial cell area.max	Area	Pt	Cornea.left	Qn	null	EYE.SPECULAR MICROSCOPY	2	Left cornea Endothelial cell area.max	L cornea Endothelial cell area.max	null	TRIAL	2.72	2.72
100082-7	Endothelial cell area.mean	Area	Pt	Cornea.right	Qn	null	EYE.SPECULAR MICROSCOPY	2	Right cornea Endothelial cell area.mean	R cornea Endothelial cell area.mean	null	TRIAL	2.72	2.72
100083-5	Endothelial cell area.mean	Area	Pt	Cornea.left	Qn	null	EYE.SPECULAR MICROSCOPY	2	Left cornea Endothelial cell area.mean	L cornea Endothelial cell area.mean	null	TRIAL	2.72	2.72
100084-3	Cell area.standard deviation	Area	Pt	Cornea.right	Qn	null	EYE.SPECULAR MICROSCOPY	2	Right cornea Cell area.standard deviation	R cornea Cell area.sd	null	TRIAL	2.72	2.72
100085-0	Cell area.standard deviation	Area	Pt	Cornea.left	Qn	null	EYE.SPECULAR MICROSCOPY	2	Left cornea Cell area.standard deviation	L cornea Cell area.sd	null	TRIAL	2.72	2.72
100086-8	Analysis method	Type	Pt	Cornea.right	Nom	Specular microscopy	EYE.SPECULAR MICROSCOPY	2	Right cornea Type of Analysis method by Specular microscopy	R cornea Analysis method	null	TRIAL	2.72	2.72
100087-6	Toxocara canis 24-35kD Ab.IgG	PrThr	Pt	Ser	Ord	IB	MICRO	1	Toxocara canis 24-35kD IgG Ab [Presence] in Serum by Immunoblot	T canis 24-35kD IgG Ser Ql IB	null	ACTIVE	2.72	2.72
100088-4	Taenia solium larva Ab bands panel	-	Pt	Ser	-	IB	PANEL.MICRO	1	Taenia solium larva Ab bands panel - Serum by Immunoblot	T solium Ab bands Pnl Ser IB	null	ACTIVE	2.72	2.72
100089-2	Taenia solium larva 6-8kD Ab	PrThr	Pt	Ser	Ord	IB	MICRO	1	Taenia solium larva 6-8kD Ab [Presence] in Serum by Immunoblot	T solium 6-8kD Ab Ser Ql IB	null	ACTIVE	2.72	2.72
1000-9	DBG Ab	PrThr	Pt	Ser/Plas^BPU	Ord	null	BLDBK	1	DBG Ab [Presence] in Serum or Plasma from Blood product unit	DBG Ab SerPl BPU Ql	null	ACTIVE	1.0	2.56
100090-0	Taenia solium larva 45kD Ab	PrThr	Pt	Ser	Ord	IB	MICRO	1	Taenia solium larva 45kD Ab [Presence] in Serum by Immunoblot	T solium 45kD Ab Ser Ql IB	null	ACTIVE	2.72	2.72
100091-8	Trypanosoma cruzi Ab	ACnc	Pt	Ser	Qn	IA	MICRO	1	Trypanosoma cruzi Ab [Units/volume] in Serum by Immunoassay	T cruzi Ab Ser IA-aCnc	null	ACTIVE	2.72	2.72

100002-5

Specimen care is maintained

Find

Pt

^Patient

Ord

null

SURVEY.PNDS

4

Specimen care is maintained

null

ACTIVE

2.72

100003-3

Team communication is maintained throughout care

Find

Pt

^Patient

Ord

null

SURVEY.PNDS

4

Team communication is maintained throughout care

null

ACTIVE

2.72

100004-1

Demonstrates knowledge of the expected psychosocial responses to the procedure

Find

Pt

^Patient

Ord

null

SURVEY.PNDS

4

Demonstrates knowledge of the expected psychosocial responses to the procedure

null

ACTIVE

2.72

100005-8

Demonstrates knowledge of nutritional management related to the procedure

Find

Pt

^Patient

Ord

null

SURVEY.PNDS

4

Demonstrates knowledge of nutritional management related to the procedure

null

ACTIVE

2.72

100006-6

Demonstrates knowledge of medication management

Find

Pt

^Patient

Ord

null

SURVEY.PNDS

4

Demonstrates knowledge of medication management

null

ACTIVE

2.72

100007-4

Demonstrates knowledge of pain management

Find

Pt

^Patient

Ord

null

SURVEY.PNDS

4

Demonstrates knowledge of pain management

null

ACTIVE

2.72

10000-8

R wave duration.lead AVR

Time

Pt

Heart

Qn

EKG

EKG.MEAS

2

R wave duration in lead AVR

R wave dur L-AVR

null

ACTIVE

1.0i

2.48

100008-2

Demonstrates knowledge of wound management

Find

Pt

^Patient

Ord

null

SURVEY.PNDS

4

Demonstrates knowledge of wound management

null

ACTIVE

2.72

100009-0

Demonstrates knowledge of the procedure and expected results

Find

Pt

^Patient

Ord

null

SURVEY.PNDS

4

Demonstrates knowledge of the procedure and expected results

null

ACTIVE

2.72

100010-8

No injury related to procedure equipment, medical supplies, or instrumentation

Find

Pt

^Patient

Ord

null

SURVEY.PNDS

4

No injury related to procedure equipment, medical supplies, or instrumentation

null

ACTIVE

2.72

100011-6

No injury related to an electrical source

Find

Pt

^Patient

Ord

null

SURVEY.PNDS

4

No injury related to an electrical source

null

ACTIVE

2.72

100012-4

Participates in decisions affecting the patient's plan of care

Find

Pt

^Patient

Ord

null

SURVEY.PNDS

4

Participates in decisions affecting the patient's plan of care

null

ACTIVE

2.72

100013-2

Participates in the discharge process

Find

Pt

^Patient

Ord

null

SURVEY.PNDS

4

Participates in the discharge process

null

ACTIVE

2.72

100014-0

Psychosocial health is maintained at or improved from baseline

Find

Pt

^Patient

Ord

null

SURVEY.PNDS

4

Psychosocial health is maintained at or improved from baseline

null

ACTIVE

2.72

100015-7

No injury related to positioning due to care or procedure

Find

Pt

^Patient

Ord

null

SURVEY.PNDS

4

No injury related to positioning due to care or procedure

null

ACTIVE

2.72

10001-6

R wave duration.lead I

Time

Pt

Heart

Qn

EKG

EKG.MEAS

2

R wave duration in lead I

R wave dur L-I

null

ACTIVE

1.0i

2.48

100016-5

No injury related to a laser source

Find

Pt

^Patient

Ord

null

SURVEY.PNDS

4

No injury related to a laser source

null

ACTIVE

2.72

100017-3

Perioperative nursing data set outcomes panel

-

Pt

^Patient

-

PNDS

PANEL.SURVEY.PNDS

4

Perioperative nursing data set outcomes panel [PNDS]

null

©AORN Syntegrity, Inc. Used with permission.Commercial or facility use requires a license from AORN Syntegrity or an authorized reseller.

ACTIVE

2.72

100018-1

Note

Find

Pt

{Setting}

Doc

Hospice care

DOC.ONTOLOGY

2

Hospice care Note

null

ACTIVE

2.72

100019-9

ALK gene targeted mutation analysis

Prid

Pt

Bld/Tiss

Nom

Molgen

MOLPATH.MUT

1

ALK gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

ALK gene Mut Anl Bld/T

null

ACTIVE

2.72

100020-7

GNA11 gene targeted mutation analysis

Prid

Pt

Bld/Tiss

Nom

Molgen

MOLPATH.MUT

1

GNA11 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

GNA11 gene Mut Anl Bld/T

null

ACTIVE

2.72

100021-5

GNAQ gene targeted mutation analysis

Prid

Pt

Bld/Tiss

Nom

Molgen

MOLPATH.MUT

1

GNAQ gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

GNAQ gene Mut Anl Bld/T

null

ACTIVE

2.72

100022-3

IDH1 gene targeted mutation analysis

Prid

Pt

Bld/Tiss

Nom

Molgen

MOLPATH.MUT

1

IDH1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

IDH1 gene Mut Anl Bld/T

null

ACTIVE

2.72

100023-1

IDH2 gene targeted mutation analysis

Prid

Pt

Bld/Tiss

Nom

Molgen

MOLPATH.MUT

1

IDH2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

IDH2 gene Mut Anl Bld/T

null

ACTIVE

2.72

10002-4

R wave duration.lead II

Time

Pt

Heart

Qn

EKG

EKG.MEAS

2

R wave duration in lead II

R wave dur L-II

null

ACTIVE

1.0i

2.48

100024-9

SETBP1 gene targeted mutation analysis

Prid

Pt

Bld/Tiss

Nom

Molgen

MOLPATH.MUT

1

SETBP1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

SETBP1 gene Mut Anl Bld/T

null

ACTIVE

2.72

100025-6

SRSF2 gene targeted mutation analysis

Prid

Pt

Bld/Tiss

Nom

Molgen

MOLPATH.MUT

1

SRSF2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

SRSF2 gene Mut Anl Bld/T

null

ACTIVE

2.72

100026-4

MET gene targeted mutation analysis

Prid

Pt

Bld/Tiss

Nom

Molgen

MOLPATH.MUT

1

MET gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

MET gene Mut Anl Bld/T

null

ACTIVE

2.72

100027-2

SMAD4 gene targeted mutation analysis

Prid

Pt

Bld/Tiss

Nom

Molgen

MOLPATH.MUT

1

SMAD4 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

SMAD4 gene Mut Anl Bld/T

null

ACTIVE

2.72

100028-0

FBXW7 gene targeted mutation analysis

Prid

Pt

Bld/Tiss

Nom

Molgen

MOLPATH.MUT

1

FBXW7 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

FBXW7 gene Mut Anl Bld/T

null

ACTIVE

2.72

100029-8

Cancer related multigene analysis

Find

Pt

Plas.cfDNA

Doc

Molgen

MOLPATH

1

Cancer related multigene analysis in Plasma cell-free DNA by Molecular genetics method

Cancer multigene analysis Plas.cfDNA

null

ACTIVE

2.72

100030-6

Axis I: Temporal aspects score

Score

Pt

^Patient

Qn

Mainz Pain Staging System

SURVEY.PAIN

4

Axis I: Temporal aspects score [Mainz Pain Staging System]

null

ACTIVE

2.72

100031-4

Axis II: Spatial aspects score

Score

Pt

^Patient

Qn

Mainz Pain Staging System

SURVEY.PAIN

4

Axis II: Spatial aspects score [Mainz Pain Staging System]

null

ACTIVE

2.72

10003-2

R wave duration.lead III

Time

Pt

Heart

Qn

EKG

EKG.MEAS

2

R wave duration in lead III

R wave dur L-III

null

ACTIVE

1.0i

2.48

100032-2

Axis III: Drug taking behavior score

Score

Pt

^Patient

Qn

Mainz Pain Staging System

SURVEY.PAIN

4

Axis III: Drug taking behavior score [Mainz Pain Staging System]

null

ACTIVE

2.72

100033-0

Axis IV: Utilization of the health care system score

Score

Pt

^Patient

Qn

Mainz Pain Staging System

SURVEY.PAIN

4

Axis IV: Utilization of the health care system score [Mainz Pain Staging System]

null

ACTIVE

2.72

100034-8

Provider of automated external defibrillator use

Type

Pt

^Patient

Nom

null

TRAUMA

2

Provider of automated external defibrillator use

Provider of AED

null

ACTIVE

2.72

100035-5

Exam finding location

Find

Pt

Chest

Nom

null

H&P.PX

2

Exam finding location of Chest

Exam finding location Chest

null

ACTIVE

2.72

100036-3

Exam finding location

Find

Pt

Lung

Nom

null

H&P.PX

2

Exam finding location of Lung

Exam finding location Lung

null

ACTIVE

2.72

100037-1

Patient contact disposition

Type

Pt

EMS unit

Nom

null

TRAUMA

2

Patient contact disposition EMS unit

null

ACTIVE

2.72

100038-9

Patient evaluation disposition

Type

Pt

EMS unit

Nom

null

TRAUMA

2

Patient evaluation disposition EMS unit

Patient eval disposition EMS unit

null

ACTIVE

2.72

100039-7

Crew disposition for patient care

Type

Pt

EMS unit

Nom

null

TRAUMA

2

Crew disposition for patient care EMS unit

Crew disposition EMS unit

null

ACTIVE

2.72

10004-0

R wave duration.lead V1

Time

Pt

Heart

Qn

EKG

EKG.MEAS

2

R wave duration in lead V1

R wave dur L-V1

null

ACTIVE

1.0i

2.48

100040-5

Patient transport disposition

Type

Pt

EMS unit

Nom

null

TRAUMA

2

Patient transport disposition EMS unit

Pt transport disposition EMS unit

null

ACTIVE

2.72

100041-3

Aminoglycoside

Susc

Pt

Isolate

OrdQn

null

ABXBACT

1

Aminoglycoside [Susceptibility]

Aminoglycoside Susc Islt

null

ACTIVE

2.72

100042-1

Atovaquone

Susc

Pt

Isolate

OrdQn

null

ABXBACT

1

Atovaquone [Susceptibility]

Atovaquone Susc Islt

null

ACTIVE

2.72

100043-9

Azithromycin+Ethambutol

Susc

Pt

Isolate

OrdQn

null

ABXBACT

1

Azithromycin+Ethambutol [Susceptibility]

Azithro+Ethambut Susc Islt

null

ACTIVE

2.72

100044-7

Cefcapene

Susc

Pt

Isolate

OrdQn

null

ABXBACT

1

Cefcapene [Susceptibility]

Cefcapene Susc Islt

null

ACTIVE

2.72

100045-4

Cefozopran

Susc

Pt

Isolate

OrdQn

null

ABXBACT

1

Cefozopran [Susceptibility]

Cefozopran Susc Islt

null

ACTIVE

2.72

100046-2

Cefquinome

Susc

Pt

Isolate

OrdQn

null

ABXBACT

1

Cefquinome [Susceptibility]

CEQ Susc Islt

null

ACTIVE

2.72

100047-0

Cefteram

Susc

Pt

Isolate

OrdQn

null

ABXBACT

1

Cefteram [Susceptibility]

Cefteram Susc Islt

null

ACTIVE

2.72

100048-8

Clarithromycin+Ethambutol

Susc

Pt

Isolate

OrdQn

null

ABXBACT

1

Clarithromycin+Ethambutol [Susceptibility]

Clarithro+Ethamb Susc Islt

null

ACTIVE

2.72

100049-6

Eravacycline

Susc

Pt

Isolate

OrdQn

null

ABXBACT

1

Eravacycline [Susceptibility]

Eravacycline Susc Islt

null

ACTIVE

2.72

100050-4

Erythromycin+Ethambutol

Susc

Pt

Isolate

OrdQn

null

ABXBACT

1

Erythromycin+Ethambutol [Susceptibility]

Erythro+Ethamb Susc Islt

null

ACTIVE

2.72

100051-2

Ethambutol+rifAMPin

Susc

Pt

Isolate

OrdQn

null

ABXBACT

1

Ethambutol+rifAMPin [Susceptibility]

Ethambutol+rifAMPin Susc Islt

null

ACTIVE

2.72

100052-0

Flomoxef

Susc

Pt

Isolate

OrdQn

null

ABXBACT

1

Flomoxef [Susceptibility]

Flomoxef Susc Islt

null

ACTIVE

2.72

100053-8

Fluoroquinolone

Susc

Pt

Isolate

OrdQn

null

ABXBACT

1

Fluoroquinolone [Susceptibility]

FLQ Susc Islt

null

ACTIVE

2.72

100054-6

Gamithromycin

Susc

Pt

Isolate

OrdQn

null

ABXBACT

1

Gamithromycin [Susceptibility]

Gamithromycin Susc Islt

null

ACTIVE

2.72

100055-3

Optochin

Susc

Pt

Isolate

OrdQn

null

ABXBACT

1

Optochin [Susceptibility]

Optochin Susc Islt

null

ACTIVE

2.72

100056-1

Panipenem

Susc

Pt

Isolate

OrdQn

null

ABXBACT

1

Panipenem [Susceptibility]

Panipenem Susc Islt

null

ACTIVE

2.72

10005-7

R wave duration.lead V2

Time

Pt

Heart

Qn

EKG

EKG.MEAS

2

R wave duration in lead V2

R wave dur L-V2

null

ACTIVE

1.0i

2.48

100057-9

Prothionamide

Susc

Pt

Isolate

OrdQn

null

ABXBACT

1

Prothionamide [Susceptibility]

Prothionamide Susc Islt

null

ACTIVE

2.72

100058-7

Prulifloxacin

Susc

Pt

Isolate

OrdQn

null

ABXBACT

1

Prulifloxacin [Susceptibility]

Prulifloxacin Susc Islt

null

ACTIVE

2.72

100059-5

Rifapentine

Susc

Pt

Isolate

OrdQn

null

ABXBACT

1

Rifapentine [Susceptibility]

Rifapentine Susc Islt

null

ACTIVE

2.72

100060-3

Tildipirosin

Susc

Pt

Isolate

OrdQn

null

ABXBACT

1

Tildipirosin [Susceptibility]

Tildipirosin Susc Islt

null

ACTIVE

2.72

100061-1

Tosufloxacin

Susc

Pt

Isolate

OrdQn

null

ABXBACT

1

Tosufloxacin [Susceptibility]

Tosufloxacin Susc Islt

null

ACTIVE

2.72

100062-9

Standard Dermatology Outcome Measures panel

-

Pt

^Patient

-

SDOM

PANEL.CLIN

2

Standard Dermatology Outcome Measures panel

SDOM panel

ACTIVE

2.72

100063-7

Primary skin concern

Find

Pt

^Patient

Nom

null

CLIN

2

Primary skin concern

null

ACTIVE

2.72

100064-5

Itch severity

Find

RptPeriod

^Patient

Ord

Reported

CLIN

2

Itch severity Reporting Period - Reported

Itch severity RptPeriod Reported

null

ACTIVE

2.72

10006-5

R wave duration.lead V3

Time

Pt

Heart

Qn

EKG

EKG.MEAS

2

R wave duration in lead V3

R wave dur L-V3

null

ACTIVE

1.0i

2.48

100065-2

Satisfied with treatment

Find

Pt

^Patient

Ord

null

CLIN

2

Satisfied with treatment

null

ACTIVE

2.72

100066-0

Specular microscopy panel

-

Pt

Eye

-

Specular microscopy

PANEL.EYE

2

Specular microscopy panel

null

TRIAL

2.72

100067-8

Image magnification

Len

Pt

Eye

Qn

null

EYE.SPECULAR MICROSCOPY

2

Eye Image magnification

null

TRIAL

2.72

100068-6

Fixation point

Angle

Pt

Eye.right

Nom

null

EYE.SPECULAR MICROSCOPY

2

Right eye Fixation point [Angle]

R eye Fixation point [Angle]

null

TRIAL

2.72

100069-4

Fixation point

Angle

Pt

Eye.left

Nom

null

EYE.SPECULAR MICROSCOPY

2

Left eye Fixation point [Angle]

L eye Fixation point [Angle]

null

TRIAL

2.72

100070-2

Cell density

Naric

Pt

Cornea.right

Qn

null

EYE.SPECULAR MICROSCOPY

2

Right cornea Cell density

R cornea Cell density

null

TRIAL

2.72

100071-0

Cell density

Naric

Pt

Cornea.left

Qn

null

EYE.SPECULAR MICROSCOPY

2

Left cornea Cell density

L cornea Cell density

null

TRIAL

2.72

100072-8

Coefficient of variation

ArLen

Pt

Cornea.right

Qn

null

EYE.SPECULAR MICROSCOPY

2

Right cornea Coefficient of variation

R cornea Coefficient of variation

null

TRIAL

2.72

10007-3

R wave duration.lead V4

Time

Pt

Heart

Qn

EKG

EKG.MEAS

2

R wave duration in lead V4

R wave dur L-V4

null

ACTIVE

1.0i

2.48

100073-6

Coefficient of variation

ArLen

Pt

Cornea.left

Qn

null

EYE.SPECULAR MICROSCOPY

2

Left cornea Coefficient of variation

L cornea Coefficient of variation

null

TRIAL

2.72

100074-4

Hexagonality

RelRto

Pt

Cornea.right

Qn

null

EYE.SPECULAR MICROSCOPY

2

Right cornea Hexagonality

R cornea Hexagonality

null

TRIAL

2.72

100075-1

Hexagonality

RelRto

Pt

Cornea.left

Qn

null

EYE.SPECULAR MICROSCOPY

2

Left cornea Hexagonality

L cornea Hexagonality

null

TRIAL

2.72

100076-9

Endothelial cells counted

Num

Pt

Cornea.right

Qn

null

EYE.SPECULAR MICROSCOPY

2

Right cornea Endothelial cells counted

R cornea Endothelial cells counted

null

TRIAL

2.72

100077-7

Endothelial cells counted

Num

Pt

Cornea.left

Qn

null

EYE.SPECULAR MICROSCOPY

2

Left cornea Endothelial cells counted

L cornea Endothelial cells counted

null

TRIAL

2.72

100078-5

Endothelial cell area.min

Area

Pt

Cornea.right

Qn

null

EYE.SPECULAR MICROSCOPY

2

Right cornea Endothelial cell area.min

R cornea Endothelial cell area.min

null

TRIAL

2.72

100079-3

Endothelial cell area.min

Area

Pt

Cornea.left

Qn

null

EYE.SPECULAR MICROSCOPY

2

Left cornea Endothelial cell area.min

L cornea Endothelial cell area.min

null

TRIAL

2.72

100080-1

Endothelial cell area.max

Area

Pt

Cornea.right

Qn

null

EYE.SPECULAR MICROSCOPY

2

Right cornea Endothelial cell area.max

R cornea Endothelial cell area.max

null

TRIAL

2.72

10008-1

R wave duration.lead V5

Time

Pt

Heart

Qn

EKG

EKG.MEAS

2

R wave duration in lead V5

R wave dur L-V5

null

ACTIVE

1.0i

2.48

100081-9

Endothelial cell area.max

Area

Pt

Cornea.left

Qn

null

EYE.SPECULAR MICROSCOPY

2

Left cornea Endothelial cell area.max

L cornea Endothelial cell area.max

null

TRIAL

2.72

100082-7

Endothelial cell area.mean

Area

Pt

Cornea.right

Qn

null

EYE.SPECULAR MICROSCOPY

2

Right cornea Endothelial cell area.mean

R cornea Endothelial cell area.mean

null

TRIAL

2.72

100083-5

Endothelial cell area.mean

Area

Pt

Cornea.left

Qn

null

EYE.SPECULAR MICROSCOPY

2

Left cornea Endothelial cell area.mean

L cornea Endothelial cell area.mean

null

TRIAL

2.72

100084-3

Cell area.standard deviation

Area

Pt

Cornea.right

Qn

null

EYE.SPECULAR MICROSCOPY

2

Right cornea Cell area.standard deviation

R cornea Cell area.sd

null

TRIAL

2.72

100085-0

Cell area.standard deviation

Area

Pt

Cornea.left

Qn

null

EYE.SPECULAR MICROSCOPY

2

Left cornea Cell area.standard deviation

L cornea Cell area.sd

null

TRIAL

2.72

100086-8

Analysis method

Type

Pt

Cornea.right

Nom

Specular microscopy

EYE.SPECULAR MICROSCOPY

2

Right cornea Type of Analysis method by Specular microscopy

R cornea Analysis method

null

TRIAL

2.72

100087-6

Toxocara canis 24-35kD Ab.IgG

PrThr

Pt

Ser

Ord

IB

MICRO

1

Toxocara canis 24-35kD IgG Ab [Presence] in Serum by Immunoblot

T canis 24-35kD IgG Ser Ql IB

null

ACTIVE

2.72

100088-4

Taenia solium larva Ab bands panel

-

Pt

Ser

-

IB

PANEL.MICRO

1

Taenia solium larva Ab bands panel - Serum by Immunoblot

T solium Ab bands Pnl Ser IB

null

ACTIVE

2.72

100089-2

Taenia solium larva 6-8kD Ab

PrThr

Pt

Ser

Ord

IB

MICRO

1

Taenia solium larva 6-8kD Ab [Presence] in Serum by Immunoblot

T solium 6-8kD Ab Ser Ql IB

null

ACTIVE

2.72

1000-9

DBG Ab

PrThr

Pt

Ser/Plas^BPU

Ord

null

BLDBK

1

DBG Ab [Presence] in Serum or Plasma from Blood product unit

DBG Ab SerPl BPU Ql

null

ACTIVE

1.0

2.56

100090-0

Taenia solium larva 45kD Ab

PrThr

Pt

Ser

Ord

IB

MICRO

1

Taenia solium larva 45kD Ab [Presence] in Serum by Immunoblot

T solium 45kD Ab Ser Ql IB

null

ACTIVE

2.72

100091-8

Trypanosoma cruzi Ab

ACnc

Pt

Ser

Qn

IA

MICRO

1

Trypanosoma cruzi Ab [Units/volume] in Serum by Immunoassay

T cruzi Ab Ser IA-aCnc

null

ACTIVE

2.72